Johnson & Johnson
JNJ
#21
Rank
โ‚ฌ417.86 B
Marketcap
173,44ย โ‚ฌ
Share price
-0.27%
Change (1 day)
25.68%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2025 (TTM): โ‚ฌ82.46 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is โ‚ฌ79.14 Billion. In 2024 the company made a revenue of โ‚ฌ85.35 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ77.03 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ82.46 B-3.39%
2024 โ‚ฌ85.35 B10.8%
2023 โ‚ฌ77.03 B-9.34%
2022 โ‚ฌ84.97 B2.62%
2021 โ‚ฌ82.80 B23.33%
2020 โ‚ฌ67.14 B-8.34%
2019 โ‚ฌ73.25 B2.72%
2018 โ‚ฌ71.31 B11.92%
2017 โ‚ฌ63.71 B-6.77%
2016 โ‚ฌ68.34 B6.64%
2015 โ‚ฌ64.08 B4.86%
2014 โ‚ฌ61.11 B18.36%
2013 โ‚ฌ51.63 B1.61%
2012 โ‚ฌ50.82 B1.49%
2011 โ‚ฌ50.07 B8.15%
2010 โ‚ฌ46.30 B7.17%
2009 โ‚ฌ43.20 B-5.25%
2008 โ‚ฌ45.59 B8.98%
2007 โ‚ฌ41.84 B3.54%
2006 โ‚ฌ40.41 B-5.23%
2005 โ‚ฌ42.64 B22.17%
2004 โ‚ฌ34.90 B4.98%
2003 โ‚ฌ33.25 B-4.24%
2002 โ‚ฌ34.72 B-5.63%
2001 โ‚ฌ36.79 B17.36%
2000 โ‚ฌ31.35 B13.38%
1999 โ‚ฌ27.65 B38.7%
1998 โ‚ฌ19.93 B4.54%
1997 โ‚ฌ19.06 B4.67%
1996 โ‚ฌ18.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ53.92 B-31.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.17 B-30.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.41 B-38.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ40.81 B-48.43%๐Ÿ‡ซ๐Ÿ‡ท France
Stryker Corporation
SYK
โ‚ฌ20.94 B-73.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚ฌ29.37 B-62.89%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
โ‚ฌ51.03 B-35.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ37.65 B-52.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.37 B-54.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
โ‚ฌ24.98 B-68.44%๐Ÿ‡บ๐Ÿ‡ธ USA